Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (1y) (2010 - 2018)
Teva Pharmaceutical Industries (TEVA) Dividends Paid - Common Growth (1y) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | 6.20% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Alkermes | 8.17 Bn | 7.51 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -96.53% |
| Dec 31, 2017 | -74.86% |
| Sep 30, 2017 | -63.82% |
| Jun 30, 2017 | 11.29% |
| Mar 31, 2017 | 12.70% |
| Dec 31, 2016 | 19.31% |
| Sep 30, 2016 | 18.47% |
| Jun 30, 2016 | 7.64% |
| Mar 31, 2016 | 5.86% |
| Dec 31, 2015 | 6.62% |
| Sep 30, 2015 | -2.38% |
| Jun 30, 2015 | -3.68% |
| Mar 31, 2015 | -0.34% |
| Dec 31, 2014 | -1.45% |
| Sep 30, 2014 | 11.36% |
| Jun 30, 2014 | 11.57% |
| Mar 31, 2014 | 3.56% |
| Dec 31, 2013 | 28.97% |
| Sep 30, 2013 | 11.39% |
| Jun 30, 2013 | 16.52% |